Profiel
Frank Benesch-Lee was the founder and had worked as a Chief Engineer at Myomics, Inc. which was founded in 2003.
He obtained his undergraduate degree from Technische Hochschule Rosenheim in 2001.
Eerdere bekende functies van Frank Benesch-Lee
| Bedrijven | Functie | Einde |
|---|---|---|
Myomics, Inc.
 Myomics, Inc. Pharmaceuticals: GenericHealth Technology Myomics, Inc. developed drugs to treat neuromuscular disease indications, such as muscle atrophy in the elderly and muscle wasting in chronic illness, included cancer and muscular dystrophy disorders. It had discovery programs based on its two proprietary technology platforms: tissue-engineered muscle, which can be generated in vitro from human and animal models of normal and diseased muscle, and opto-mechanical systems to monitor the ability of candidate compounds to increase the contractile strength of tissue-engineered muscle. The company was founded in 2003 and headquartered in Providence, RI. | Oprichter | - |
Opleiding van Frank Benesch-Lee
| Technische Hochschule Rosenheim | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Myomics, Inc.
Myomics, Inc. Pharmaceuticals: GenericHealth Technology Myomics, Inc. developed drugs to treat neuromuscular disease indications, such as muscle atrophy in the elderly and muscle wasting in chronic illness, included cancer and muscular dystrophy disorders. It had discovery programs based on its two proprietary technology platforms: tissue-engineered muscle, which can be generated in vitro from human and animal models of normal and diseased muscle, and opto-mechanical systems to monitor the ability of candidate compounds to increase the contractile strength of tissue-engineered muscle. The company was founded in 2003 and headquartered in Providence, RI. | Health Technology |
